Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial.
D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use*; D016227:Benzoquinones / Q000494:pharmacology / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005621:Friedreich Ataxia / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000000981:diagnostic imaging / Q000209:etiology / Q000517:prevention & control*; D008929:Mitochondria, Heart / Q000187:drug effects / Q000502:physiology; D018384:Oxidative Stress; D014451:Ubiquinone / Q000031:analogs & derivatives; D014463:Ultrasonography
D000975:Antioxidants; D016227:Benzoquinones; D002316:Cardiotonic Agents; D014451:Ubiquinone; C036619:idebenone